AMERICAN MEDICAL SYSTEMS LOGO American Medical Systems, Inc. logo. (PRNewsFoto)[AG] MINNEAPOLIS, MN USA

    MINNEAPOLIS, July 17 /PRNewswire/ --
    American Medical Systems Holdings, Inc. (Nasdaq: AMMD), announced today
that the underwriters in its recent secondary offering have exercised their
entire over-allotment option to purchase an additional 1,050,000 shares of
common stock of American Medical Systems Holdings, Inc.  The underwriters
purchased the over-allotment shares from Warburg, Pincus Equity Partners, L.P.
at a public offering price of $16.40.
    (Photo:  http://www.newscom.com/cgi-bin/prnh/20000710/AMSLOGO )
    On June 27, AMS completed a secondary offering of 7,000,000 shares of
common stock at $16.40; 3,500,000 shares were sold by the company, with the
balance sold by Warburg, Pincus.  The offering generated approximately
$53.6 million for AMS, which the company will use to repay debt and fund
growth.  The offering was managed by U.S. Bancorp Piper Jaffray and co-managed
by Banc of America Securities LLC, JPMorgan H&Q and Robertson Stephens.
    American Medical Systems, headquartered in Minneapolis, is a medical
technology company with 500 employees worldwide.  American Medical Systems
products include a large portfolio of devices to treat both male and female
incontinence, devices for the diagnosis and treatment of erectile dysfunction,
devices for urethral obstruction caused by benign prostatic hyperplasia (BPH)
(enlarged prostate disease) and advanced surgical products used in
transurethral resection of the prostate.
    To request a copy of the final prospectus for the offering, write to U.S.
Bancorp Piper Jaffray Equity Capital Markets, 800 Nicollet Mall, Suite 800,
Minneapolis, Minn. 55402-7020.

Link to this page: